Elizabeth Gough-Gordon

Teens with a later weekday bedtime more likely to experience increased BMI over time.

New study is the first to link genetic variation to glucose tolerance with melatonin supplementation.

Although ICD-10 will allow greater specificity and clinical accuracy in noting procedures and diagnoses, the transition presents challenges.

Substituting polyunsaturated fatty acids, carbohydrates from whole grains significantly decreased risk.

Study in mice suggests link between exercise and lower risk for increased marrow adipose tissue.

The FDA has approved the Orberal Intragastric Balloon as a non-surgical weight loss procedure for patients with obesity.

Unilife Corporation announced the launch of the Imperium, the first instant patch pump for insulin with Bluetooth connectivity for patients with diabetes.

Government agencies are considering a stronger regulatory role in ensuring that connected medical devices can’t be “hacked.”

One in five patients with hypertension reported that exercise was not recommended to them by their health care provider.

The Food and Drug Administration (FDA) announced that Bystolic (nebivolol; Forest Laboratories) 20 mg is currently in shortage.

Novo Nordisk announced the launch of Saxenda (liraglutide) injection for chronic weight management in adults with obesity or overweight and at least one weight-related comorbidity.

Researchers have discovered that a common medication indicated for the treatment of high cholesterol may stimulate the same peroxisome proliferator-activated receptors (PPARs) as cannabinoids, which could lead to a new class of cannabis-like drugs to treat a range of conditions.